ACHILLION PHARMACEUTICALS INC·4

Dec 18, 4:24 PM ET

Scheer David 4

4 · ACHILLION PHARMACEUTICALS INC · Filed Dec 18, 2018

Insider Transaction Report

Form 4
Period: 2018-12-14
Scheer David
Director
Transactions
  • Exercise/Conversion

    Common Stock

    2018-12-14$1.05/sh+20,000$21,00020,000 total
  • Exercise/Conversion

    Employee Stock Option

    2018-12-1420,0000 total
    Exercise: $1.05Exp: 2018-12-15Common Stock (20,000 underlying)
Holdings
  • Common Stock

    (indirect: See footnote)
    63,249
Footnotes (2)
  • [F1]Consists of shares held by Scheer Investment Holdings III, LLC. Mr. Scheer is the Managing Member of Scheer Investment Holdings III, LLC. and as such may be deemed to have shared voting and investment power with respect to the shares held by Scheer Investment Holdings III, LLC. Mr. Scheer disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
  • [F2]This option was granted on December 15, 2008 and vested over a four year period with 25% of the shares vesting on the first anniversary of the grant date and an additional 6.25% vesting at the end of each three-month period thereafter.

Documents

2 files